Our study indicated that the protein expression of three markers (FGFR1, LDHB, and MYPT1) were correlated with prostate cancer patients' outcomes (biochemical recurrence) in tumor-adjacent stroma, and such correlations were surprisingly opposite to those in tumor tissues. This evidence concerns the gene FGFR1 and prostate cancer.